Xaliproden is a bioactive compound. References: Ng L, Khan F, Young CA, Galea M. Symptomatic treatments for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev. 2017 Jan 10;CD011776. doi: 10.1002/14651858.CD011776.pub2. Review. PubMed PMID: 28072907.

纯度：≥98%

CAS：135354-02-8